The future of AI drug discovery & development in immunology and GPCR research
pharmaphorum
SEPTEMBER 16, 2022
The companies hope that in the year to come those data targets will be entered for validation, hit generation, and lead selection. AI relies on data. Speed and cost-effectiveness are one thing, but without good data to act upon, results are meaningless. AI drug discovery in immunology today, and tomorrow. About the interviewee.
134 
Let's personalize your content